PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.12%
Revenue growth above 1.5x 5715.T's 3.34%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
83.86%
Gross profit growth above 1.5x 5715.T's 10.31%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
157.15%
Positive EBIT growth while 5715.T is negative. John Neff might see a substantial edge in operational management.
156.65%
Operating income growth above 1.5x 5715.T's 58.17%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
103.24%
Positive net income growth while 5715.T is negative. John Neff might see a big relative performance advantage.
103.25%
Positive EPS growth while 5715.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
103.25%
Positive diluted EPS growth while 5715.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Reduced diluted shares while 5715.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.00%
Negative 10Y revenue/share CAGR while 5715.T stands at 35.42%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-25.53%
Negative 5Y CAGR while 5715.T stands at 11.77%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
10.49%
3Y revenue/share CAGR under 50% of 5715.T's 22.18%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
100.00%
10Y OCF/share CAGR in line with 5715.T's 100.00%. Walter Schloss would see both as similarly efficient over the decade.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.17%
Net income/share CAGR at 75-90% of 5715.T's 128.36%. Bill Ackman would press for strategic moves to boost long-term earnings.
-96.98%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-91.65%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
36.28%
5Y equity/share CAGR at 75-90% of 5715.T's 45.20%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
29.51%
3Y equity/share CAGR above 1.5x 5715.T's 17.61%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.18%
AR growth well above 5715.T's 4.75%. Michael Burry fears inflated revenue or higher default risk in the near future.
9.15%
We show growth while 5715.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
8.03%
Asset growth above 1.5x 5715.T's 2.32%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-3.51%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
16.11%
Debt growth far above 5715.T's 16.65%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
7.37%
We expand SG&A while 5715.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.